Johnson and Johnson says Levaquin patent upheld
LOS ANGELES, Dec 23 (Reuters) - Johnson and Johnson (JNJ.N: Quote, Profile, Research) on Thursday said a U.S. District Court upheld its patent on the antibiotic Levaquin and found that the patent was infringed by generic drugmaker Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research)